
Selected Grants and Scholarships
2013 Interdisciplinary Perspectives on Time Collaborative Grant
Centre for Time, University of Sydney
2011 ASBDD-AZ Scholarship Research Scholarship
Australian Society for Bipolar and Depressive Disorders
2011 Neuroscience Research Grant Research Grant
Pfizer
2010 Young Investigator Grant Research Grant
Royal Australian and New Zealand College of Psychiatrists
Selected Peer Reviewed Publications
1. Berk, M., Mohebbi, M., Dean, O. M., Cotton, S. M., Chanen, A. M., Dodd, S.,
Ratheesh, A., Amminger, G. P., Phelan, M., Weller, A., Mackinnon, A., Giorlando,
F., Baird, S., Incerti, L., Brodie, R. E., . . . Davey, C. G. (2020). Youth Depression
Alleviation with Anti-inflammatory Agents (YoDA-A): A randomised clinical trial
of rosuvastatin and aspirin. BMC Medicine, 18(1), 16. https://doi.org/10.
1186/s12916-019-1475-6
2. Dean, O. M., Gliddon, E., Van Rheenen, T. E., Giorlando, F., Davidson, S. K.,
Kaur, M., Ngo, T. T., & Williams, L. J. (2018). An update on adjunctive treatment
options for bipolar disorder. Bipolar Disorders, 20(2), 87–96. https://doi.org/
10.1111/bdi.12601
3. Van Rheenen, T. E., Davidson, S. K., Giorlando, F., Gliddon, E., & Dean, O.
M. (2015). Fostering early and mid-career research in aective disorders. The
Australian and New Zealand Journal of Psychiatry, 49(4), 387–388. https://
doi.org/10.1177/0004867414566473
4. Dandash, O., Harrison, B. J., Adapa, R., Gaillard, R., Giorlando, F., Wood,
S. J., Fletcher, P. C., & Fornito, A. (2014). Selective Augmentation of Striatal
Functional Connectivity Following NMDA Receptor Antagonism: Implications for
Psychosis. Neuropsychopharmacology. https://doi.org/10.1038/npp.2014.
210
5. Giorlando, F., Markanday, S., Anderson, A., Carpenter, R., & Berk, M.
(2014). Temporal Order Assessment in Patients with Bipolar Disorder. Procedia
- Social and Behavioral Sciences, 126, 216. https://doi.org/10.1016/j.
sbspro.2014.02.381
6. Giorlando, F., Teister, J., Dodd, S., Udina, M., & Berk, M. (2013).
Hyponatraemia: An Audit of Aged Psychiatry Patients Taking SSRIs and SNRIs.
Current Drug Safety, 8(3), 175–180.
7. Moore, J. W., Cambridge, V. C., Morgan, H., Giorlando, F., Adapa, R., &
Fletcher, P. C. (2013). Time, action and psychosis: Using subjective time to
investigate the eects of ketamine on sense of agency. Neuropsychologia,
51(2), 377–384. https://doi.org/10.1016/j.neuropsychologia.2012.07.
005
8. Berk, M., Berk, L., Davey, C. G., Moylan, S., Giorlando, F., Singh, A. B., Kalra,
H., & Malhi, G. S. (2012). Treatment of bipolar depression. Medical Journal
of Australia Open, 1(4), 32–35. http://cat.inist.fr/?aModele=afficheN&
cpsidt=27278349
9. Dean, D. O. M., Data-Franco, J., Giorlando, F., & Berk, M. (2012).
Minocycline. CNS Drugs, 26(5), 391–401. https://doi.org/10.2165/
11632000-000000000-00000
10. Dodd, S., Malhi, G. S., Tiller, J., Schweitzer, I., Hickie, I., Khoo, J. P., Basset,
D. L., Lyndon, B., Mitchell, P. B., Parker, G., Fitzgerald, P. B., Udina, M., Singh,
A., Moylan, S., Giorlando, F., . . . Berk, M. (2012). O-10 - Safety monitoring
guidelines for treatments for major depressive disorder. European Psychiatry,
27, Supplement 1, 1. https://doi.org/10.1016/S0924-9338(12)74110-X
11. Moylan, S., Giorlando, F., Nordfjærn, T., & Berk, M. (2012). The role of
alprazolam for the treatment of panic disorder in Australia. Australian and New
Curriculum Vitae: Dr Francesco Giorlando 2